February 27, 2020 / 11:35 PM / a month ago

BRIEF-Nektar Therapeutics Reports Q4 Loss Per Share $0.64

Feb 27 (Reuters) - Nektar Therapeutics:

* REPORTS FOURTH QUARTER AND YEAR-END 2019 FINANCIAL RESULTS

* Q4 REVENUE ESTIMATE $26.9 MILLION — REFINITIV IBES DATA

* Q4 EARNINGS PER SHARE ESTIMATE $-0.68 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below